• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. LEAD MODEL 304

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. LEAD MODEL 304 Back to Search Results
Model Number 304-20
Device Problem Fracture (1260)
Patient Problems Chest Pain (1776); Seizures (2063); Neck Pain (2433)
Event Date 08/09/2018
Event Type  malfunction  
Event Description
It was reported that a patient¿s device is showing high impedance.It was reported the patient's seizure activity has increased and she sometimes feels a "zap" in her neck or chest.It was reported that her (b)(6) head-butted her in the chest.The patient was sent for an x-ray of the neck and chest however there were no lead breaks observed.No known surgical intervention has occurred to date.No additional or relevant information has been received to date.
 
Event Description
The patient had a lead replacement surgery.The explanted device has not been received for analysis to date.
 
Event Description
Product analysis on the lead was completed and approved.The lead was returned due to lead fracture, lead break, and high impedance.The analysis did not confirm a discontinuity in the returned portion of the device which may have contributed to the stated allegation.A significant portion of the lead (including the electrode array) was not returned for analysis, therefore an evaluation and resulting commentary cannot be made on that portion of the lead.Sets of setscrew marks were seen on the marked connector pin providing evidence that proper contact between the setscrew and the marked connector pin existed at least once.The condition of the returned lead portion is consistent with conditions that typically exist following an explant procedure.No obvious anomalies were noted.
 
Event Description
The lead was received for analysis.Analysis is currently underway.Additional information was received that the surgeon did reinsert the pin two different times prior to the lead revision and lead impedance was still high after both times.He verified that the lead was pushed past the second connector block.No additional or relevant information has been received to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEAD MODEL 304
Type of Device
LEAD
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
njemile crawley
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key7826426
MDR Text Key118553893
Report Number1644487-2018-01517
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 12/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date07/31/2018
Device Model Number304-20
Device Lot Number203022
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/29/2018
Is the Reporter a Health Professional? Yes
Event Location Other
Initial Date Manufacturer Received 08/09/2018
Initial Date FDA Received08/29/2018
Supplement Dates Manufacturer Received09/07/2018
10/27/2018
11/29/2018
Supplement Dates FDA Received10/02/2018
11/20/2018
12/11/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/12/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age48 YR
-
-